CHIDIMMA NZOIWU: Open Payments
NPI 1396262812 · MARIETTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$673 in 11 payments from 6 companies in 2025. Trend: 2023 $588 · 2024 $684 · 2025 $673
Food & beverage: $673
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 3 | $155 |
| Alkermes, Inc. | 2 | $143 |
| E.R. Squibb & Sons, L.L.C. | 2 | $135 |
| ABBVIE INC. | 1 | $116 |
| Janssen Pharmaceuticals, Inc | 1 | $92 |
| Otsuka America Pharmaceutical, Inc. | 2 | $32 |
Products named: UZEDY, COBENFY, LYBALVI, VRAYLAR, INVEGA SUSTENNA, ABILIFY MAINTENA, ARISTADA, REXULTI.
Industry payments across GA — which companies pay providers there.
